Contingency management targeting increased completion of hepatitis B (Hep B) vaccination amongst people in treatment for heroin dependence

Completed

• Conditions: Addiction opiate dependence; Mental and Behavioural Disorders; Opiate addiction

• Registration Number: ISRCTN72794493
• Lead Sponsor: South London & Maudsley NHS Foundation Trust and Kings College London (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-04-01
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 192

Inclusion Criteria

1. Aged greater than 18 years, either sex
2. New episode of opiate treatment (within first 2 months)
3. Previous, current, or at risk of engaging in risk behaviour (i.e. injecting drug use)
4. Willing to receive vaccination
5. Willing to provide informed consent

Exclusion Criteria

1. Pregnant or breastfeeding
2. Received prior hepatitis B vaccination course
3. Current or past hepatitis B infection

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Successful completion of the three Hep B vaccination injections (days 1, 7 and 21) within 28 days. Participants will be defined as completers if they receive all three injections by day 28.

Secondary Outcome Measures

Name	Time	Method
1. On-time attendance<br>2. For those who do not complete, the proportion of vaccination doses received